Clinical Trial Update: A Study of PM8002 in Combination With Chemotherapy in Patients With NEN [Phase 2]

View source ↗

Summary

Biotheus Inc. reports a Phase 2 clinical trial evaluating PM8002 in combination with chemotherapy for neuroendocrine neoplasms, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroendocrine Neoplasm

Drugs mentioned

• PM8002

Snippet

Sponsor: Biotheus Inc. | Conditions: Neuroendocrine Neoplasm | Phase 2 | Status: RECRUITING